sapropterin
sapropterin is a pharmaceutical drug with 9 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
66.7%
6 of 9 finished
33.3%
3 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Kuvan Treatment in Adults With GTPCH Deficiency
Nutritional Status in Phenylketonuria
Trial of Kuvan in Lesch-Nyhan Disease
Sapropterin as a Treatment for Autistic Disorder
Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
Clinical Trials (9)
Study of Kuvan Treatment in Adults With GTPCH Deficiency
Nutritional Status in Phenylketonuria
Trial of Kuvan in Lesch-Nyhan Disease
Sapropterin as a Treatment for Autistic Disorder
Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy
Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9